Skip to main content
. 2023 May 15;114(8):3352–3363. doi: 10.1111/cas.15834

FIGURE 4.

FIGURE 4

Kaplan–Meier curves for relapse‐free survival. Relapse‐free survival of 532 patients (61 with the KRAS G12D mutation, 17 with the KRAS G12C mutation, 51 with the KRAS G12V mutation, 51 with the KRAS G13D mutation, 51 with other KRAS mutations, and 301 without KRAS mutations) were analyzed. Blue: wild‐type (no KRAS mutation). Two patients were excluded from the analysis because they had double mutations.